| Dr Usman Zafar, MD | |
|
8525 Rolling Rd Ste 200, Manassas, VA 20110-3648 | |
| (703) 257-2266 | |
| (703) 257-2269 |
| Full Name | Dr Usman Zafar |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 14 Years |
| Location | 8525 Rolling Rd Ste 200, Manassas, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932402013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 0101258281 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Prince William Medical Center | Manassas, VA | Hospital |
| Novant Health Uva Health Haymarket Medical Center | Haymarket, VA | Hospital |
| Warren Memorial Hospital | Front royal, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nova Advanced Pain Management Pllc | 8628020575 | 6 |
News Archive
Looking to harness the body's own immune system to target prostate cancer that has spread to the bones (metastatic) and is unresponsive to standard treatment, investigators at The Cancer Institute of New Jersey have just launched a clinical trial focusing on a combination of vaccine and radiation drug therapy.
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.
A pioneering digital histopathology partnership between Sheffield Teaching Hospitals, Hull and East Yorkshire Hospitals and Philips offering a groundbreaking solution to the growing demand for specialist histopathology services at a time when fewer pathologists are entering the profession has been launched.
NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
| Entity Name | Nova Advanced Pain Management Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912023466 PECOS PAC ID: 8628020575 Enrollment ID: O20050228000217 |
News Archive
Looking to harness the body's own immune system to target prostate cancer that has spread to the bones (metastatic) and is unresponsive to standard treatment, investigators at The Cancer Institute of New Jersey have just launched a clinical trial focusing on a combination of vaccine and radiation drug therapy.
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.
A pioneering digital histopathology partnership between Sheffield Teaching Hospitals, Hull and East Yorkshire Hospitals and Philips offering a groundbreaking solution to the growing demand for specialist histopathology services at a time when fewer pathologists are entering the profession has been launched.
NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Usman Zafar, MD 8525 Rolling Rd Ste 200, Manassas, VA 20110-3648 Ph: (703) 257-2266 | Dr Usman Zafar, MD 8525 Rolling Rd Ste 200, Manassas, VA 20110-3648 Ph: (703) 257-2266 |
News Archive
Looking to harness the body's own immune system to target prostate cancer that has spread to the bones (metastatic) and is unresponsive to standard treatment, investigators at The Cancer Institute of New Jersey have just launched a clinical trial focusing on a combination of vaccine and radiation drug therapy.
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.
A pioneering digital histopathology partnership between Sheffield Teaching Hospitals, Hull and East Yorkshire Hospitals and Philips offering a groundbreaking solution to the growing demand for specialist histopathology services at a time when fewer pathologists are entering the profession has been launched.
NanoVibronix, a medical device company, announced that the US Food and Drug Administration (FDA) has granted 510K clearance to market PainShield MD, a diathermy device used to treat pain. PainShield is the first hands-free, patch-based diathermy device, thus allowing for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. The PainShield consists of a disposable patch connected to a portable reusable driver and generates ultrasound waves to the desired area of the body.
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 8 days ago
Dr. Deeni Bassam, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 8525 Rolling Rd, Suite 200, Manassas, VA 20110 Phone: 703-257-2266 Fax: 703-257-2269 |